About
Regina Hodits is a Munich-based life sciences investor and, since April 7, 2025, Managing Director at Angelini Ventures, where she helps lead the firm's international biotech strategy. Previously she was Managing Partner at Wellington Partners and earlier held investment roles at Atlas Venture and Apax Partners. Her public profiles emphasize more than two decades in biotech venture investing, board work, and exits including Rigontec, Sapiens, Middle Peak Medical, and Themis.
Areas of interest
biotechdigital healthmedtechtherapeuticsbiotech AIoncologyradiopharmaceuticalswomen's healthimmunologymicrobiome